VCU Massey Cancer Center

Menu

Massey radiation oncologist Emma Fields honored with Educator of the Year award

Emma Fields, M.D.

Virginia Commonwealth University (VCU) Massey Cancer Center radiation oncologist Emma Fields, M.D., was recognized on May 1, 2017, as VCU Health’s Educator of the Year by the Association of Residents in Radiation Oncology (ARRO) for her excellence in teaching and enthusiastic support of residency training. ARRO strives to promote and recognize educational excellence in radiation oncology training programs, and each year it presents the annual Educator of the Year award to one outstanding faculty member at each participating institution. 

“I am incredibly honored. Our residents took the time out of their busy schedules to nominate me for this award. I really love what I do and love working with residents every day,” explains Fields. “I love seeing our residents progress through their training and become competent in all aspect of radiation oncology – in the clinic, treatment planning and the understanding and application of evidence-based practices.”

Dr. Emma Fields awarded VCU Health’s Educator of the Year by the Association of Residents in Radiation Oncology (ARRO)

Fields was nominated by Nicholas Serrano, M.D., chief resident in the Department of Radiation Oncology, and Serrano’s fellow residents. She has been with VCU for close to four years. In addition to providing radiation therapy for patients with gastrointestinal and gynecologic cancers, Fields is a member of the Developmental Therapeutics research program at Massey and is an assistant professor in radiation oncology at the VCU School of Medicine.

A physician-scientist, Fields is currently co-leading a clinical trial studying the effectiveness of chemotherapy combined with radiation therapy to shrink pancreatic tumors prior to surgery. In addition, she recently published the results of a study in Journal of Gastrointestinal Oncology supporting more aggressive treatment of pancreatic cancer prior to surgery, and she recently led the world’s first implementation of a new radiation device to treat early stage pancreatic cancer.

Written by: Massey Communications Office

Posted on: May 18, 2017

Category: Center news & funding